🗞️ News - April 17, 2025

Mark Cuban Cost Plus Drug Company Collaborates with Morris & Dickson for Medication Access

Mark Cuban Cost Plus Drug Company partners with Morris & Dickson to enhance access to essential injectable medications. 💊🤝

🌟 Stay Updated!
Join AI Health Hub to receive the latest insights in health and AI.

Mark Cuban Cost Plus Drug Company Collaborates with Morris & Dickson for Medication Access

Partnership Overview

Morris & Dickson, a specialty pharmaceutical distributor, has formed a partnership with the Mark Cuban Cost Plus Drug Company (MCCPDC) and the Cost Plus Marketplace. This collaboration aims to enhance access to essential injectable medications.

Key Features of the Partnership
  • MCCPDC provides a wide selection of affordable prescription and over-the-counter medications sourced from National Association of Boards of Pharmacy (NABP) accredited suppliers.
  • The Cost Plus Marketplace facilitates direct access to medications for hospitals, clinics, surgery centers, university health networks, and pharmacies at reduced prices.
  • This partnership seeks to address drug shortages by ensuring a reliable supply of rare injectable drugs, particularly for acute care providers.
Goals and Benefits

The collaboration aims to:

  1. Improve access to essential medications at lower prices for healthcare providers.
  2. Offer flexible options without volume commitments.
  3. Streamline the procurement process through the Cost Plus Marketplace platform.
Statements from Leadership

Mark Cuban, co-founder of MCCPDC, stated, “This partnership reshapes the supply chain for injectable medications. Together, we are not just filling gaps; we’re creating a more transparent, efficient, and patient-centered system.”

Jody Hatcher, CEO of Morris & Dickson, emphasized that this collaboration sets a new standard for the reliable sourcing of critical medications, stating, “This is about more than distribution; it’s about putting pharmacies and patients first.”

Recent Trends in Medication Access

In 2024, eNavvi, an online pharmacy founded by physicians, partnered with MCCPDC to allow physicians to prescribe medications directly through eNavvi’s digital prescription pad to over 7,000 independent pharmacies and national grocery pharmacy chains.

Additionally, in 2023, MCCPDC collaborated with various organizations, including:

  • Wheel – a virtual care staffing and services company.
  • Talkspace – a mental health platform.
  • Health Gorilla – a diagnostic services company.

Furthermore, MCCPDC has partnered with PharmcoRx Pharmacy and Expion Health to reduce drug prices for consumers, integrating MCCPDC’s pricing into their offerings.

Conclusion

This partnership between Morris & Dickson and MCCPDC represents a significant step towards improving medication access and affordability for healthcare providers and patients alike.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on whatsapp
WhatsApp

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.